Published July 25, 2024 | Version v1
Journal article Open

HYENA detects oncogenes activated by distal enhancers in cancer

Description

Somatic structural variations (SVs) in cancer can shuffle DNA content in the genome, relocate regulatory elements, and alter genome organization. Enhancer hijacking occurs when SVs relocate distal enhancers to activate proto-oncogenes. However, most enhancer hijacking studies have only focused on protein-coding genes. Here, we develop a computational algorithm 'HYENA' to identify candidate oncogenes (both protein-coding and non-coding) activated by enhancer hijacking based on tumor whole-genome and transcriptome sequencing data. HYENA detects genes whose elevated expression is associated with somatic SVs by using a rank-based regression model. We systematically analyze 1146 tumors across 25 types of adult tumors and identify a total of 108 candidate oncogenes including many non-coding genes. A long non-coding RNA TOB1-AS1 is activated by various types of SVs in 10% of pancreatic cancers through altered 3-dimensional genome structure. We find that high expression of TOB1-AS1 can promote cell invasion and metastasis. Our study highlights the contribution of genetic alterations in non-coding regions to tumorigenesis and tumor progression.

Data availability

The HYENA package is available at https://github.com/yanglab-computationalgenomics/HYENA (permanent DOI 10.5281/zenodo.12683789).

Files

HYENA-detects-oncogenes-activated-by-distal-enhancers-in-cancer.pdf

Files (12.1 MB)

Name Size Download all
Supplementary data
md5:278c50b6dcd5893b75589cebcefd3a8d
9.4 MB Preview Download
Article
md5:6e06a9d320e72135644486b8a50a8881
2.7 MB Preview Download

Additional details

Identifiers

DOI
10.1093/nar/gkae646
Other
oai:uchicago.tind.io:13010

Funding

University of Chicago
University of Chicago Medicine Comprehensive Cancer Center
National Institutes of Health
K22CA193848
National Institutes of Health
R01CA269977

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Ben May Department for Cancer Research, Human Genetics
Center(s) or Institute(s)
Comprehensive Cancer Center